Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -14.76%982.79M | -11.98%1.06B | -31.88%801.37M | 8.91%4.7B | 5.96%1.19B | 4.44%1.15B | 5.72%1.21B | 23.61%1.18B | -5.11%4.32B | -8.01%1.12B |
| Cost of revenue | -6.32%94.72M | -4.26%96.72M | -5.21%3.97B | -16.48%100.33M | -4.49%94.89M | 4.80%101.11M | 6.31%101.02M | 5.34%4.19B | -96.68%120.13M | |
| Gross profit | -12.49%969.09M | -34.47%704.66M | 457.68%734.57M | 8.65%1.09B | 5.32%1.06B | 5.81%1.11B | 25.53%1.08B | -77.17%131.72M | 141.70%999.55M | |
| Operating expense | 13.39%1.17B | -8.99%876.08M | 7.68%1.16B | 16.31%471.16M | -0.41%1.39B | -18.23%1.03B | -17.42%962.58M | 15.49%1.08B | 22.92%405.08M | 147.41%1.4B |
| Selling and administrative expenses | ---- | ---- | ---- | 16.31%471.16M | ---- | ---- | ---- | ---- | 22.92%405.08M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 16.31%471.16M | ---- | ---- | ---- | ---- | 22.92%405.08M | ---- |
| Depreciation and amortization | -3.95%91.14M | -6.32%94.72M | -4.26%96.72M | ---- | -16.48%100.33M | -4.49%94.89M | 4.80%101.11M | 6.31%101.02M | ---- | --120.13M |
| -Depreciation | -3.95%91.14M | -6.32%94.72M | -4.26%96.72M | ---- | -16.48%100.33M | -4.49%94.89M | 4.80%101.11M | 6.31%101.02M | ---- | --120.13M |
| Other operating expenses | 14.91%1.08B | -2.93%840.86M | 8.01%1.07B | -5.89%4.13B | 0.62%1.3B | -19.84%941.66M | -19.31%866.23M | 16.86%990.04M | --4.39B | --1.29B |
| Total other operating income | -43.19%2.2M | 1,148.76%59.49M | -56.36%5.99M | -20.93%31.95M | -38.23%9.6M | -65.18%3.86M | 8.40%4.76M | 46.42%13.72M | --40.4M | 118.84%15.54M |
| Operating profit | -256.56%-188.21M | -23.68%187.72M | -462.04%-358.7M | 196.36%263.42M | 26.18%-204.34M | 175.60%120.22M | 1,195.14%245.98M | 425.26%99.08M | -210.53%-273.36M | -247.08%-276.82M |
| Net non-operating interest income (expenses) | 81.45%-43.78M | 7.05%-186.57M | 2.67%-190.73M | -5.08%-821.42M | 7.31%-188.8M | -19.09%-235.95M | -0.83%-200.71M | -8.38%-195.97M | -28.40%-781.69M | -12.41%-203.69M |
| Non-operating interest income | 157.66%24.78M | 44.32%15.04M | -28.79%6.19M | 128.65%42.12M | 213.13%13.41M | 43.20%9.62M | 230.00%10.42M | 103.40%8.69M | 31.26%18.42M | -9.99%4.28M |
| Non-operating interest expense | -72.08%68.56M | -4.51%201.6M | -3.78%196.92M | 7.93%863.55M | -2.77%202.2M | 19.88%245.56M | 4.40%211.13M | 10.57%204.65M | 28.46%800.12M | 11.84%207.97M |
| Net investment income | 80.08%-42.44M | -125.22%-238.98M | -158.62%-30.73M | -72.56%136.33M | 149.13%61.9M | -178.70%-213.06M | -178.92%-106.11M | -75.91%52.42M | 1,139.76%496.8M | 65.13%-126M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 91.28%129.5M | 27.54%121.53M | -27.34%91.21M | 22.53%413.19M | 233.36%124.67M | -58.06%67.7M | -37.10%95.29M | 6.56%125.53M | 973.63%337.22M | 56.58%-93.49M |
| Special income (charges) | 6,547,872.06%4.45B | -420.21%-602K | 116.84%17.75M | 2,414.02%595.33M | 5,661.74%767.63M | 99.43%-68K | 840.00%188K | -105.41M | 99.01%-25.73M | 99.47%-13.8M |
| Less:Impairment of capital assets | --0 | --654K | ---- | 242.68%88.5M | 541.19%88.5M | --0 | --0 | ---- | -97.77%25.83M | -98.81%13.8M |
| Less:Other special charges | -6,567,600.00%-4.47B | 72.34%-52K | -116.84%-17.75M | -820,731.63%-804.42M | ---976.72M | 187.18%68K | -840.00%-188K | --105.41M | 98.87%-98K | ---- |
| Less:Write off | --13.42M | --3.86M | ---- | --67K | --67K | --0 | --0 | ---- | --0 | --0 |
| Less:Negative goodwill immediately recognized | ---- | ---- | ---- | --120.52M | --120.52M | ---- | ---- | ---- | --0 | --0 |
| Other non-operating income (expenses) | -66.57%-276.65M | -25.77%-166.08M | ||||||||
| Income before tax | 1,749.39%4.31B | -437.47%-116.9M | -1,834.83%-471.19M | 175.14%310.19M | 178.60%561.07M | -514.38%-261.16M | -46.26%34.64M | -114.04%-24.35M | 86.70%-412.84M | 78.38%-713.8M |
| Income tax | 59.24%39.63M | 188.67%112.43M | -54.16%12.95M | 128.66%242.06M | 729.63%149.97M | -20.31%24.89M | 44.41%38.95M | -4.50%28.25M | 47.09%105.86M | 164.68%18.08M |
| Net income | 1,592.02%4.27B | -5,224.54%-229.33M | -820.37%-484.14M | 113.14%68.14M | 156.17%411.1M | -999.73%-286.05M | -111.49%-4.31M | -136.56%-52.6M | 83.67%-518.7M | 77.64%-731.88M |
| Net income continuous operations | 1,592.02%4.27B | -5,224.54%-229.33M | -820.37%-484.14M | 113.14%68.14M | 156.17%411.1M | -999.73%-286.05M | -111.49%-4.31M | -136.56%-52.6M | 83.67%-518.7M | 77.64%-731.88M |
| Noncontrolling interests | -169.33%-4.86M | 55.28%1.43M | 95.41%-6.18M | -1,108.82%-121.39M | 257.40%5.41M | 674.48%7.01M | 117.29%919K | -6,040.88%-134.73M | 43.73%-10.04M | 78.22%-3.44M |
| Net income attributable to the company | 1,557.99%4.27B | -4,315.52%-230.76M | -681.96%-477.96M | 137.26%189.53M | 155.69%405.68M | -1,048.78%-293.06M | -112.21%-5.23M | -43.78%82.13M | 83.89%-508.66M | 77.64%-728.44M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1,557.99%4.27B | -4,315.52%-230.76M | -681.96%-477.96M | 137.26%189.53M | 155.69%405.68M | -1,048.78%-293.06M | -112.21%-5.23M | -43.78%82.13M | 83.89%-508.66M | 77.64%-728.44M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 688.52%1.8715 | -4,100.00%-0.252 | -677.78%-0.52 | 132.49%0.206 | 151.04%0.442 | -936.84%-0.318 | -111.11%-0.006 | -50.55%0.09 | 83.96%-0.634 | 78.75%-0.866 |
| Diluted earnings per share | 322.33%0.707 | -4,100.00%-0.252 | -677.78%-0.52 | 132.49%0.206 | 151.04%0.442 | -1,035.29%-0.318 | -111.11%-0.006 | -50.55%0.09 | 83.96%-0.634 | 78.75%-0.866 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.